Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Crowther

Showing results (211-220 of 286) with videos related to

Pageof 29
Sort By:
Journal of Thrombosis and Haemostasis : JTH|June 3, 2020
Recurrent thrombosis in patients with antiphospholipid antibodies and an initial venous or arterial thromboembolic event: A systematic review and meta-analysisThomas L Ortel, Sreelatha Meleth, Diane Catellier, et al.
Research and Practice in Thrombosis and Haemostasis|October 27, 2025
Andexanet alfa for the reversal of the low-molecular-weight heparin enoxaparinThijs F van Haaps, Alexander P Benz, Lizhen Xu, et al.
European Journal of Epidemiology|July 3, 2016
Comparison of treatment effect estimates of non-vitamin K antagonist oral anticoagulants versus warfarin between observational studies using propensity score methods and randomized controlled trialsGuowei Li, Anne Holbrook, Yanling Jin, et al.
The Annals of Pharmacotherapy|December 20, 2014
Integrating electronic health records in the delivery of optimized anticoagulation therapyEdith A Nutescu, Ann K Wittkowsky, Daniel M Witt, et al.
European Journal of Epidemiology|June 28, 2018
Direct comparative effectiveness and safety between non-vitamin K antagonist oral anticoagulants for stroke prevention in nonvalvular atrial fibrillation: a systematic review and meta-analysis of observational studiesGuowei Li, Gregory Y H Lip, Anne Holbrook, et al.
Chest|February 9, 2012
Diagnosis of DVT: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesShannon M Bates, Roman Jaeschke, Scott M Stevens, et al.
Chest|February 9, 2012
Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesClive Kearon, Elie A Akl, Anthony J Comerota, et al.
Journal of Critical Care|April 13, 2011
PROphylaxis for ThromboEmbolism in Critical Care Trial protocol and analysis planDeborah Cook, Maureen Meade, Gordon Guyatt, et al.
American Journal of Hematology|July 18, 2009
Prevention and treatment of bleeding complications in patients receiving vitamin K antagonists, part 2: TreatmentWalter Ageno, David Garcia, Maria I Aguilar, et al.
Blood Advances|January 4, 2018
Safety, pharmacokinetics, and reversal of apixaban anticoagulation with andexanet alfaDeborah Siegal, Genmin Lu, Janet M Leeds, et al.
Pageof 29

Showing results (211-220 of 286) with videos related to

Sort By:
Pageof 29
Journal of Thrombosis and Haemostasis : JTH|June 3, 2020
Recurrent thrombosis in patients with antiphospholipid antibodies and an initial venous or arterial thromboembolic event: A systematic review and meta-analysisThomas L Ortel, Sreelatha Meleth, Diane Catellier, et al.
Research and Practice in Thrombosis and Haemostasis|October 27, 2025
Andexanet alfa for the reversal of the low-molecular-weight heparin enoxaparinThijs F van Haaps, Alexander P Benz, Lizhen Xu, et al.
European Journal of Epidemiology|July 3, 2016
Comparison of treatment effect estimates of non-vitamin K antagonist oral anticoagulants versus warfarin between observational studies using propensity score methods and randomized controlled trialsGuowei Li, Anne Holbrook, Yanling Jin, et al.
The Annals of Pharmacotherapy|December 20, 2014
Integrating electronic health records in the delivery of optimized anticoagulation therapyEdith A Nutescu, Ann K Wittkowsky, Daniel M Witt, et al.
European Journal of Epidemiology|June 28, 2018
Direct comparative effectiveness and safety between non-vitamin K antagonist oral anticoagulants for stroke prevention in nonvalvular atrial fibrillation: a systematic review and meta-analysis of observational studiesGuowei Li, Gregory Y H Lip, Anne Holbrook, et al.
Chest|February 9, 2012
Diagnosis of DVT: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesShannon M Bates, Roman Jaeschke, Scott M Stevens, et al.
Chest|February 9, 2012
Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesClive Kearon, Elie A Akl, Anthony J Comerota, et al.
Journal of Critical Care|April 13, 2011
PROphylaxis for ThromboEmbolism in Critical Care Trial protocol and analysis planDeborah Cook, Maureen Meade, Gordon Guyatt, et al.
American Journal of Hematology|July 18, 2009
Prevention and treatment of bleeding complications in patients receiving vitamin K antagonists, part 2: TreatmentWalter Ageno, David Garcia, Maria I Aguilar, et al.
Blood Advances|January 4, 2018
Safety, pharmacokinetics, and reversal of apixaban anticoagulation with andexanet alfaDeborah Siegal, Genmin Lu, Janet M Leeds, et al.
Pageof 29